June 2025 Price Concessions Final Update
The Department of Health and Social Care (DHSC) has today (01/07/2025) confirmed the following final list of price concessions for June 2025.
Drug | Pack size | Price concession |
Ascorbic acid 100mg tablets | 28 | £26.89 |
Co-amoxiclav 250mg/62mg/5ml oral suspension | 100 | £5.06 |
Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free | 100 | £4.79 |
Fenofibrate micronised 160mg tablets | 28 | £3.60 |
Mercaptopurine 50mg tablets | 25 | £9.70 |
Midazolam 10mg/2ml solution for injection ampoules | 10 | £5.64 |
Nizatidine 150mg capsules | 30 | £21.69 |
Sulfasalazine 500mg tablets | 112 | £6.61 |
Venlafaxine 225mg modified-release capsules | 28 | £18.45 |
For the full list of price concessions granted for June 2025 please visit our price concession hub page here.
Notes : No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions)